Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,552.00    -48.00 (-3.00%)
Bid:
1,544.00
Ask:
1,547.00
Spread: 3.00 (0.194%)
Market Cap: £1.58b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Directorate Change

27 Apr 2022 07:00

RNS Number : 4419J
Greggs PLC
27 April 2022
 

 

 

 

GREGGS plc

 

Board Changes

The Board of Greggs plc announces that it has appointed Lynne Weedall as an independent non-executive director, with effect from 17 May 2022. Lynne will join the Board immediately following the close of the Annual General Meeting currently scheduled on that date.

Lynne is an experienced People and Business Transformation executive, having held senior positions most recently at Selfridges, and before that at Carphone Warehouse. Throughout her executive career Lynne has been involved in and led transformational projects in several of the companies she has worked for, which have also included Whitbread, and BUPA.

Lynne is currently the senior independent non-executive director and Remuneration Committee Chair at Dr. Martens plc, and at Stagecoach plc, and on 3 May 2022 is due to join the Board of Softcat plc as non-executive director and Chair of the Remuneration Committee. Lynne is also a non-executive director and Nominations Committee chair at Treatt plc. Lynne was previously a non-executive director and Remuneration Committee Chair of Greene King plc from 2012 until 2019 and William Hill plc from 2019 until April 2021.

The Board intends that Lynne will be appointed as Chair of the Remuneration Committee when Helena Ganczakowski steps down from the Board in 2023.

Ian Durant, Chair of Greggs, said "We are delighted that such an experienced non-executive director has accepted our invitation to join the Board. Lynne brings with her extensive experience of HR & transformational change, and will add significant value to our Board during this transitional phase and beyond".

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Lynne Weedall.

ENDS

ENQUIRIES:

 

 

Greggs plc

Hudson Sandler

Roger Whiteside, Chief Executive

Richard Hutton, Finance Director

Hattie Dreyfus / Nick Moore / Sophie Miles

Tel: 0191 281 7721

 

Tel: 020 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPURWCUPPGMQ
Date   Source Headline
9th May 20187:00 amRNSTRADING UPDATE
27th Apr 201811:18 amRNSAnnual Financial Report
17th Apr 201811:42 amRNSNotice of Trading Update
4th Apr 20183:34 pmRNSDirector/PDMR Shareholding
4th Apr 20183:33 pmRNSDirector/PDMR Shareholding
28th Mar 20184:35 pmRNSDirector/PDMR Shareholding
28th Mar 20184:34 pmRNSDirector/PDMR Shareholding
27th Mar 201810:12 amRNSDirector/PDMR Shareholding
27th Mar 201810:12 amRNSDirector/PDMR Shareholding
23rd Mar 20189:16 amRNSHolding(s) in Company
27th Feb 20187:00 amRNSPreliminary Results
16th Feb 20187:52 amRNSDirector/PDMR Shareholding
7th Feb 20183:17 pmRNSHolding(s) in Company
2nd Feb 20184:31 pmRNSHolding(s) in Company
2nd Feb 20188:33 amRNSNotice of Results
16th Jan 20187:00 amRNSFOURTH QUARTER TRADING UPDATE
11th Jan 20184:27 pmRNSHolding(s) in Company
7th Dec 20173:43 pmRNSNotice of Trading Update
6th Dec 20179:21 amRNSBlock listing Interim Review
6th Dec 20179:20 amRNSBlock listing Interim Review
28th Nov 20178:00 amRNSNotification of a Change to a Director's Details
5th Oct 20174:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSTrading Update
19th Sep 20172:15 pmRNSNotice of Trading Update
17th Aug 201710:57 amRNSHolding(s) in Company
1st Aug 20177:00 amRNSInterim Results
6th Jul 20178:38 amRNSNotice of Interim Results
9th Jun 20171:59 pmRNSHolding(s) in Company
6th Jun 201710:14 amRNSBlock listing Interim Review
6th Jun 201710:03 amRNSBlock listing Interim Review
6th Jun 20179:31 amRNSDirector/PDMR Shareholding
6th Jun 20179:31 amRNSDirector/PDMR Shareholding
30th May 201710:21 amRNSHolding(s) in Company
23rd May 201711:56 amRNSDirector/PDMR Shareholding
23rd May 201711:52 amRNSDirector/PDMR Shareholding
22nd May 201710:11 amRNSDirectorate Change
19th May 20175:37 pmRNSResult of AGM
18th May 20177:00 amRNSTrading Update
4th May 201712:11 pmRNSNOTICE OF TRADING UPDATE
28th Apr 20178:10 amRNSDirectorate Change
19th Apr 20174:39 pmRNSDirector/PDMR Shareholding
19th Apr 20174:36 pmRNSDirector/PDMR Shareholding
13th Apr 201712:29 pmRNSDirector/PDMR Shareholding
13th Apr 201712:27 pmRNSDirector/PDMR Shareholding
13th Apr 201712:26 pmRNSDirector/PDMR Shareholding
11th Apr 20174:53 pmRNSDirector/PDMR Shareholding
5th Apr 20178:42 amRNSAnnual Financial Report
27th Mar 20172:22 pmRNSDirectorate Change
27th Mar 201710:32 amRNSDirector/PDMR Shareholding
27th Mar 201710:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.